ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis
NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD
Taking everything into account, ADUS scores 6 out of 10 in our fundamental rating. ADUS was compared to 103 industry peers in the Health Care Providers & Services industry. ADUS scores excellent on profitability, but there are some minor concerns on its financial health. ADUS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ADUS had positive earnings in the past year.
In the past year ADUS had a positive cash flow from operations.
ADUS had positive earnings in each of the past 5 years.
ADUS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ADUS has a Return On Assets of 5.61%. This is amongst the best in the industry. ADUS outperforms 80.58% of its industry peers.
ADUS's Return On Equity of 7.94% is fine compared to the rest of the industry. ADUS outperforms 68.93% of its industry peers.
The Return On Invested Capital of ADUS (6.56%) is better than 67.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADUS is below the industry average of 9.62%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.61% | ||
| ROE | 7.94% | ||
| ROIC | 6.56% |
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
1.3 Margins
Looking at the Profit Margin, with a value of 6.52%, ADUS belongs to the top of the industry, outperforming 83.50% of the companies in the same industry.
ADUS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.04%, ADUS is in the better half of the industry, outperforming 78.64% of the companies in the same industry.
In the last couple of years the Operating Margin of ADUS has grown nicely.
ADUS has a better Gross Margin (32.56%) than 61.16% of its industry peers.
ADUS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.04% | ||
| PM (TTM) | 6.52% | ||
| GM | 32.56% |
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
2. Health
2.1 Basic Checks
ADUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ADUS has more shares outstanding than it did 1 year ago.
ADUS has more shares outstanding than it did 5 years ago.
ADUS has a worse debt/assets ratio than last year.
2.2 Solvency
ADUS has an Altman-Z score of 4.65. This indicates that ADUS is financially healthy and has little risk of bankruptcy at the moment.
ADUS's Altman-Z score of 4.65 is fine compared to the rest of the industry. ADUS outperforms 79.61% of its industry peers.
ADUS has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as ADUS would need 2.21 years to pay back of all of its debts.
The Debt to FCF ratio of ADUS (2.21) is better than 80.58% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that ADUS is not too dependend on debt financing.
The Debt to Equity ratio of ADUS (0.20) is better than 67.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | 4.65 |
ROIC/WACC0.77
WACC8.55%
2.3 Liquidity
A Current Ratio of 1.74 indicates that ADUS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.74, ADUS is doing good in the industry, outperforming 64.08% of the companies in the same industry.
ADUS has a Quick Ratio of 1.74. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
ADUS's Quick ratio of 1.74 is fine compared to the rest of the industry. ADUS outperforms 67.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.74 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.74% over the past year.
ADUS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.61% yearly.
ADUS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.38%.
Measured over the past years, ADUS shows a quite strong growth in Revenue. The Revenue has been growing by 12.22% on average per year.
EPS 1Y (TTM)14.74%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%17.36%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%20.29%
3.2 Future
The Earnings Per Share is expected to grow by 10.72% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.83% on average over the next years. This is quite good.
EPS Next Y18.86%
EPS Next 2Y13.43%
EPS Next 3Y13.38%
EPS Next 5Y10.72%
Revenue Next Year21.33%
Revenue Next 2Y13.28%
Revenue Next 3Y11.23%
Revenue Next 5Y8.83%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.74, which indicates a rather expensive current valuation of ADUS.
Compared to the rest of the industry, the Price/Earnings ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 68.93% of the companies listed in the same industry.
ADUS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.65, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.76, the valuation of ADUS can be described as correct.
67.96% of the companies in the same industry are more expensive than ADUS, based on the Price/Forward Earnings ratio.
ADUS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.74 | ||
| Fwd PE | 16.76 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ADUS.
Based on the Price/Free Cash Flow ratio, ADUS is valued a bit cheaper than 61.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.07 | ||
| EV/EBITDA | 17.77 |
4.3 Compensation for Growth
ADUS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ADUS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 13.38% in the coming years.
PEG (NY)1.1
PEG (5Y)1.25
EPS Next 2Y13.43%
EPS Next 3Y13.38%
5. Dividend
5.1 Amount
No dividends for ADUS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
113.01
-0.78 (-0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.71%
Inst Owner Change1.49%
Ins Owners2.26%
Ins Owner Change3.94%
Market Cap2.08B
Analysts83.53
Price Target139.18 (23.16%)
Short Float %4.67%
Short Ratio4.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.46%
Min EPS beat(2)0.48%
Max EPS beat(2)4.43%
EPS beat(4)3
Avg EPS beat(4)3.31%
Min EPS beat(4)-0.68%
Max EPS beat(4)9%
EPS beat(8)7
Avg EPS beat(8)5.05%
EPS beat(12)10
Avg EPS beat(12)5.22%
EPS beat(16)12
Avg EPS beat(16)4.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.45%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.22%
Revenue beat(12)0
Avg Revenue beat(12)-1.5%
Revenue beat(16)0
Avg Revenue beat(16)-1.89%
PT rev (1m)0.56%
PT rev (3m)0.13%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)0.35%
EPS NY rev (1m)0.63%
EPS NY rev (3m)2.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.14%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-1.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.74 | ||
| Fwd PE | 16.76 | ||
| P/S | 1.72 | ||
| P/FCF | 23.07 | ||
| P/OCF | 21.5 | ||
| P/B | 2.09 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.77 |
EPS(TTM)5.45
EY4.82%
EPS(NY)6.74
Fwd EY5.97%
FCF(TTM)4.9
FCFY4.33%
OCF(TTM)5.26
OCFY4.65%
SpS65.85
BVpS54.1
TBVpS-4.6
PEG (NY)1.1
PEG (5Y)1.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.61% | ||
| ROE | 7.94% | ||
| ROCE | 8.7% | ||
| ROIC | 6.56% | ||
| ROICexc | 7.11% | ||
| ROICexgc | 99.98% | ||
| OM | 9.04% | ||
| PM (TTM) | 6.52% | ||
| GM | 32.56% | ||
| FCFM | 7.44% |
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexcg growth 3Y20.44%
ROICexcg growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score5
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 1.61 | ||
| Cap/Depr | 47.01% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 14.16 | ||
| Cash Conversion | 78.26% | ||
| Profit Quality | 114.08% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.74 | ||
| Altman-Z | 4.65 |
F-Score5
WACC8.55%
ROIC/WACC0.77
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)14.74%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%17.36%
EPS Next Y18.86%
EPS Next 2Y13.43%
EPS Next 3Y13.38%
EPS Next 5Y10.72%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%20.29%
Revenue Next Year21.33%
Revenue Next 2Y13.28%
Revenue Next 3Y11.23%
Revenue Next 5Y8.83%
EBIT growth 1Y13.78%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year43.57%
EBIT Next 3Y17.53%
EBIT Next 5Y14.43%
FCF growth 1Y-18.04%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y-18%
OCF growth 3Y43.4%
OCF growth 5Y57.54%